Oncocyte to Present New Data on DetermaIO(TM) Test as a Predictor of Immunotherapy Response in Renal Cell Cancer at the 2021 ASCO Annual Meeting
DetermaIO now shown to predict immunotherapy response in four different tissue types suggesting potential pan-cancer applicability IRVINE, Calif., April 28, 2021 (GLOBE NEWSWIRE) — Oncocyte Corporation (Nasdaq: OCX), a molecular diagnostics company with a mission more...
Advaxis to Present at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting
PRINCETON, N.J., April 28, 2021 (GLOBE NEWSWIRE) — Advaxis, Inc. (Nasdaq: ADXS ), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today announced that will present data from Part B more...
Experion Holdings Reports Record Revenue and First Quarter of Positive Adjusted EBITDA
VANCOUVER, BC / ACCESSWIRE / April 28, 2021 / Experion Holdings Ltd. (the “Company” or “Experion“) (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31), Canada’s solution to craft cannabis supply and builder of premium cannabis brands including its sought after and popular more...
Digimarc Reports First Quarter 2021 Financial Results
Digimarc Reports First Quarter 2021 Financial Results PR Newswire BEAVERTON, Ore. , April 28, 2021 /PRNewswire/ — Digimarc Corporation (NASDAQ: DMRC), creator of the Digimarc Platform for digital identification and detection, reported financial results for more...
iCAD Reports Financial Results for First Quarter Ended March 31, 2021
First Quarter Revenues of $8.6 Million Represented 32% Year-Over-Year Growth Driven by 28% Growth in Detection Revenue and 41% Growth in Therapy Revenue ProFound AI® Product Revenue Increased 34% in the First Quarter of 2021 more...
The Top Catalysts Driving a Potential $165.7 Billion CBD Opportunity
The CBD infused product market could balloon to $165.7 billion, according to Meticulous Research at a CAGR of 48.1%. That’s already creating sizable opportunity for companies such as Pure Extracts Technologies Corp. (CSE:PULL)(OTC:PRXTF)(XFRA:A2QJAJ), Canopy Growth more...
“The Buzz” Show: ADMA Biologics (NASDAQ: ADMA) FDA Approval for IVIG Production Scale
FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “ ADMA Biologics Receives FDA Approval for Increased Intravenous Immune Globulin Production Scale ” ADMA Biologics (NASDAQ: ADMA) , Inc. shot up over 23% more...
Golden Leaf to Host Live Corporate Overview Webinar on May 4th at 2:00pm ET
PORTLAND, Ore., April 28, 2021 (GLOBE NEWSWIRE) — Golden Leaf Holdings Ltd. (CSE:GLH) (OTCQB:GLDFF) (“Golden Leaf” or the “Company”), operating as Chalice Brands, a premier, consumer-driven cannabis company specializing in retail, production, processing, wholesale, and more...
Will Adma Biologics (ADMA) Report Negative Q1 Earnings? What You Should Know
The market expects Adma Biologics (ADMA) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2021. This widely-known consensus outlook is important in assessing the more...
PowerFleet (PWFL) Earnings Expected to Grow: Should You Buy?
PowerFleet (PWFL) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2021. This widely-known consensus outlook gives a good sense of the company’s more...